| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/NDT/GFV351 |
| P698 | PubMed publication ID | 26445812 |
| P50 | author | Alan Jardine | Q42650581 |
| P2093 | author name string | Marit D Solbu | |
| P2860 | cites work | Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes | Q28188162 |
| Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research | Q28272171 | ||
| Prevalence of chronic kidney disease in the United States | Q29614191 | ||
| Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy | Q29615215 | ||
| Revascularization versus medical therapy for renal-artery stenosis | Q33515796 | ||
| Rates and predictors of ACE inhibitor discontinuation subsequent to elevated serum creatinine: a retrospective cohort study | Q34071791 | ||
| Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors | Q34448983 | ||
| Sodium zirconium cyclosilicate in hyperkalemia | Q34448992 | ||
| Time-updated systolic blood pressure and the progression of chronic kidney disease: a cohort study | Q35504141 | ||
| GFR decline and mortality risk among patients with chronic kidney disease | Q35985709 | ||
| Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial | Q36497887 | ||
| Intensive Blood-Pressure Control in Hypertensive Chronic Kidney Disease | Q36872087 | ||
| Rapid decline of kidney function increases cardiovascular risk in the elderly | Q37477773 | ||
| Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? | Q38074571 | ||
| Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts | Q41931102 | ||
| Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study | Q45206183 | ||
| Combined angiotensin inhibition for the treatment of diabetic nephropathy | Q46129784 | ||
| Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. | Q46426098 | ||
| ACE-inhibitor use and the long-term risk of renal failure in diabetes | Q57446641 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic renal insufficiency | Q736715 |
| P304 | page(s) | 171-173 | |
| P577 | publication date | 2015-10-06 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | 'To block or not to block'; whether to continue renin-angiotensin-aldosterone system blockade in advanced chronic kidney disease | |
| P478 | volume | 31 |
| Q55433025 | Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Geriatric Ischemic Stroke Patients: Are the Rates Right? | cites work | P2860 |
Search more.